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their practice for AVF construction especially when one considers
all comers, not just first time dialysis patients. Indeed, it is sobering
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Dr Samuel Eric Wilson (Long Beach, Calif). When a piece of
shrapnel, a stab to the groin, or an errant orthopedic drill can
produce an arteriovenous fistula (AVF), it occurred to some, that
vascular surgeons working in a modern operating room, aided by
magnification and 6-0 sutures, could construct a functioning AVF
almost all the time. In fact, a review of the literature does show
some case series of highly selected patients in whom the individual
surgeon using a unique technique known only to him or her can
have very high rates of AVF success. In the half million North
Americans with end-stage renal disease (ESRD), however, these
results cannot be confirmed and approximately 50% of AVFs never
function.
Our colleagues from Denver and Portland have demonstrated
that when AVFs were constructed preemptively, in anticipation of
hemodialysis, 23% of patients had never used the fistula for hemo-
dialysis at a median follow-up period of 10 months. Analysis of
these 34 patients would be worthwhile to see why they did not
proceed to hemodialysis, for example, was the creatinine too low?
Was the degree of renal failure acted upon at the time of fistula
placement accentuated by a transient but reversible event? Or was
the nephrology team slow in initiating hemodialysis? Clinical judg-
ment can vary here, and we depend on nephrologists to time the
initiation of hemodialysis. Do the authors know if any of these 34
patients have actually begun hemodialysis in the intervening
months since submission of the abstract?
The Kidney Disease Outcomes Quality Initiative (KDOQI)
guidelines have generated more interest in vascular access surgery
which was formerly an “orphan” area. A quick look at PubMed
shows 1850 articles in the last 20 years on hemodialysis and AVF
with 1400 published in the last 10 years. The authors have met the
goals stated by the NKF KDOQI guidelines (2006 update) of
having a prevalent, functional AV placement rate of greater than
65% (48 of 74) in the patients who did begin dialysis via the index
AVF. Many surgeons have experienced lower prevalence rates ino read the 2009 report from the United States Renal Data System
Foley RN, Chen SC, Collins AJ. Hemodialysis access at initiation
n the United States, 2005-2007. Hemodial Int 2009;13:533-42)
n which the proportion of patients initiating dialysis via an AVF
as only 13.2%. In fact, an astounding 63% of patients were
eceiving dialysis via a catheter alone. Worse still, the mortality rate
or patients with catheter alone was twice that for patients who had
n AVF.
After a review of 20 years of technological innovations in
emodialysis, Lameire et al (Clin J SocNephrol 2009;Suppl 1:S30-
0) concluded that these had not been translated into longer
atient survival and identified only pre-dialysis care and timely
reation of the AVF as themost effective strategy for improving the
ong-term outcome of the patient on dialysis. Accordingly, I
elieve that the 23% of patients who had a patent but not yet
ccessed AVF at 10 months should not be viewed as failures,
ecause in subsequentmonths the patients may well use this access.
What can we do to increase the number of AVFs that mature
or satisfactory vascular access and extend functional patency?
lmost all the authors’ patients had preoperative venous mapping.
Although I view this as being indispensible in the obese
atient or in the brachium to establish the diameter of the basilic
ein in the forearm, it does not seem to add much to a careful
hysical examination. I find that the AVF constructed in the
ntecubital fossa (brachiocephalic) has a more predictable out-
ome than the radiocephalic fistula. In the older patient, a vein
ransposition does not offer much advantage over a brachioaxillary
olytetrafluoroethylene (PTFE) graft in patency and carries the
isadvantage of an average 5 months of maturation time. After the
stula is established, surveillance with ultrasound scan to identify
reas in which balloon-assisted maturity may improve flow, is a
seful strategy. Because needle puncture injury is a prominent
ause of AVF thrombosis, education of dialysis technicians may
ield dividends.In summary, I suggest that the patients not on dialysis by 10
onths should not be viewed as unsatisfactory, because hemodi-
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AVF in place. Certainly, effort should be directed at developing
predictors for onset of hemodialysis perhaps linking patterns in the
creatinine clearance with the etiology of chronic kidney disease
(CKD). The KDOQI guidelines may be difficult to achieve, but
remember the KDOQI disclaimer explicitly states that the clinical
practice guidelines “are not intended to define a standard of care
and should not be construed as one.”
Dr Traci A. Kimball. Dr Wilson, thank you for your ques-
tions and for providing us with a copy of your discussion in lead of
the meeting allowing us to prepare our rebuttal with some fore-
thought.
In response to your first series of questions, the majority of
patients in this series had CKD stages IV and V, and therefore
glomerular filtration rates (GFRs) 30 mL/min/m2. Within the
nephrology literature, progression to ESRD is eminent at these
stages. It would be interesting to look at the subgroup of patients
not yet on hemodialysis to determine if they did in fact have less
severe CKD than those who progressed to hemodialysis (HD). I
should reiterate that initiation to HD is not entirely dependent on
the absolute value of one’s GFR, but also depends on a patient’s
willingness to start treatments, so this natural history is multifac- gorial. Your second question was whether there existed a trigger
hat determined the access referral. I submit that I am unable to
ake any conclusions as to the circumstances behind the referral by
ephrology. However, I can conclude that for the most part our
urgeons do not routinely question the necessity of fistula place-
ent.
As for the 34 patients not yet on HD with patent fistulas, we
ould have to re-open our data set and extend the follow-up
eview beyond our end date, December 2007. The answer would
hen depend on the completeness of the medical record.
Finally, in our surgeons’ hands, AVF placement and functional
uccess met the accepted KDOQI standards; however, this report
escribes a predominant VA population, which implies that pa-
ients are referred from a large catchment area making it impossible
o follow each and every patient longitudinally. Whereas educating
ach patient’s dialysis unit about proper fistula handling would be
he ideal, it is just not feasible with the number of patients receiving
stulas. We do not practice routine surveillance and balloon-
ssisted maturation so I cannot comment about these practices and
hether they improve outcomes.Thank you again for your questions. Thank you to the pro-
ram committee for the opportunity to present this work.
